C21H23NO4
353.4 g/mol
의약 중간체경고
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-methylbutanoic acid
CAS84000-11-3EC807-805-3
용도 분류
의약 중간체
화합물 분류
펩타이드
주요 용도
의약 중간체
This compound is a derivative of N-methyl-L-valine used as a protecting reagent in peptide synthesis. It features the Fmoc (9-fluorenylmethoxycarbonyl) group, which temporarily protects the amino group during solid-phase peptide assembly.
amino acid protecting reagentpeptide synthesis intermediate
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 84000-11-3
관련 화합물
유사구조 유사유사도 0.80
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-L-isoleucine
CAS138775-22-1
Fmoc-protected amino acid for peptide synthesis
유사구조 유사유사도 0.80
Fmoc-N-methyl-L-alloisoleucine
CAS1821797-58-3
Research compound for peptide synthesis
유사구조 유사유사도 0.77
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-N-methyl-L-alanine
CAS84000-07-7
Peptide synthesis building block
용도 관련동일 용도
Boc-glycine
CAS4530-20-5
amino acid protecting reagent
참고동일 카테고리
Chitosan, 2-hydroxypropyl ether
CAS84069-44-3
pharmaceutical excipient raw material
참고동일 카테고리
1-Benzhydrylpiperazine
CAS841-77-0
Pharmaceutical intermediate for antihistamines
참고동일 카테고리
5-Chloro-2-methyl-1-phenyl-1H-benzimidazole
CAS84100-59-4
Pharmaceutical intermediate for clobazam impurities
참고동일 카테고리
(3aS,4S,6S,7aR)-3a,5,5-Trimethyl-2-(2-methylpropyl)hexahydro-2H-4,6-methano-1,3,2-benzodioxaborole
CAS84110-34-9
boronic acid ester chiral intermediate
안전 참조
경고
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
식별자
IUPAC 이름
(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylbutanoic acid
InChIKey
YCXXXPZNQXXRIG-IBGZPJMESA-N
SMILES
CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
동의어 목록 (15)
- (S)-Fmoc-N-methylvaline
- Fmoc-MeVal-OH
- Fmoc-N-Me-L-Val-OH
- Fmoc-N-Me-Val-OH
- Fmoc-N-alpha-Methyl-L-valine
- Fmoc-N-methyl-L-valine
- N-Fmoc-N-methyl-L-valine